Are you Dr. Burfeind?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 54 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3200 Pleasant Valley Rd
Division of Hematologyoncology
West Bend, WI 53095Phone+1 262-836-7200Fax+1 262-306-7851
Summary
- Dr. John Burfeind, MD is an oncologist in West Bend, Wisconsin. He is currently licensed to practice medicine in Wisconsin, Washington, and Oregon. He is affiliated with Froedtert West Bend Hospital, Froedtert Menomonee Falls Hospital, and Ascension Columbia St. Mary's Hospital Ozaukee.
Education & Training
Medical College of Wisconsin Affiliated HospitalsFellowship, Hematology and Medical Oncology, 1996 - 1999- Medical College of Wisconsin Affiliated HospitalsResidency, Internal Medicine, 1994 - 1996
Abbott-Northwestern HospitalInternship, Internal Medicine, 1993 - 1994
University of Wisconsin School of Medicine & Public HealthClass of 1993
Certifications & Licensure
OR State Medical License 1999 - Present
WI State Medical License 1995 - 2025
WA State Medical License 2002 - 2005- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Phase 2 Study of Docetaxel +/- OGX-427 in Patients With Relapsed or Refractory Metastatic Bladder Cancer Start of enrollment: 2013 Apr 01
Publications & Presentations
PubMed
- Matched Case Control Analysis of Breast Cancer- Specific Factors Affecting Risk of Developing SARS-CoV-2 Infection.Michael Pierro, Joanna Zurko, Anika Szabo, Yee Chung Cheng, Sailaja Kamaraju
WMJ. 2023-12-01 - 2 citationsFrequent upregulation of HER2 protein in hormone-receptor-positive HER2-negative breast cancer after short-term neoadjuvant endocrine therapy.Lubna N Chaudhary, Julie M Jorns, Yunguang Sun, Yee Chung Cheng, Sailaja Kamaraju
Breast Cancer Research and Treatment. 2023-10-01 - 3 citationsAndrogen receptor expression in patients with triple negative breast cancer treated with neoadjuvant chemotherapy: a single institution study.Nithya Sridhar, Chad Glisch, Zeeshan Jawa, Lubna N Chaudhary, Sailaja Kamaraju
Journal of Cancer. 2022-01-01
